Hazard

Stability Issue recalls

66 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.

What the numbers show

Total: 66
Critical: 0
Severe: 16
Most recent: 2026-08-12

Of the 66 stability issue recalls we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 16 (24%) are Severe.

Which agencies issued them

About this hazard tag

Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all stability issue recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.

A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.

51–66 of 66

ModerateFDA (Drugs)·D-0608-2016·2016-02-03
Pharmakon Recalls Provocholine Pre-diluted Sets Due to Stability Data Issues
Pharmakon Pharmaceuticals is recalling Provocholine Pre-diluted Set II because stability data does not support the expiration dates. The recall affects lots expiring through November 17, 2015.
Product
Provocholine Pre-diluted Set II in 0.9% Sodium Chloride, 0.25 mg/mL, 3 mL in 5 mL Syr, injectable packed in syringes, Rx only, PHARMAKON Pharmaceuticals, Inc.
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1013-2015·2015-05-20
Estradiol Vaginal Cream Recalled for Sterility and Stability Concerns
Health Innovations Pharmacy is recalling Estradiol 0.01% Vaginal Cream due to inspection findings regarding sterility and stability data.
Product
Estradiol 0.01% Vaginal Cream, Health Innov Pharmacy, 295 Pinehurst Ave, Southern Pines, NC 28387, (910) 246-5155
Category
Drug
Distribution
1 state
SevereFDA (Drugs)·D-1024-2015·2015-05-20
Baclofen Suspension Recalled for Sterility and Stability Concerns
Health Innovations Pharmacy is recalling Baclofen 20 mg/4 mL Suspension due to inspection findings regarding sterility and stability data.
Product
Baclofen 20 mg/4 mL Susp., Health Innov Pharmacy, 295 Pinehurst Ave, Southern Pines, NC 28387, (910) 246-5155
Category
Drug
Distribution
1 state
HighFDA (Drugs)·D-1020-2015·2015-05-20
Pregnenolone 20 mg SR Capsules Recalled for Sterility and Stability Concerns
Health Innovations Pharmacy is recalling all lots of Pregnenolone 20 mg SR Capsules due to quality control issues affecting sterility and stability.
Product
Pregnenolone 20 mg SR Capsule, Health Innov Pharmacy, 295 Pinehurst Ave, Southern Pines, NC 28387, (910) 246-5155
Category
Drug
Distribution
1 state
HighFDA (Drugs)·D-1062-2015·2015-05-20
Hydrocortisone Suspension Recalled for Sterility and Stability Concerns
Health Innovations Pharmacy is recalling Hydrocortisone 1.6 mg/0.5 mL Suspension due to quality control issues affecting sterility and stability.
Product
Hydrocortisone 1.6 mg/0.5 mL Susp, Health Innov Pharmacy, 295 Pinehurst Ave, Southern Pines, NC 28387, (910) 246-5155
Category
Drug
Distribution
1 state
ModerateFDA (Drugs)·D-1605-2014·2014-10-01
Qualitest Recalls Subpotent Methylprednisolone Tablets Due to Stability Issues
Qualitest Pharmaceuticals is recalling specific lots of Methylprednisolone 4 mg tablets because they may be subpotent due to a 6-month stability time point issue.
Product
METHYLPREDNISOLONE — METHYLPREDNISOLONE (METHYLPREDNISOLONE)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Devices)·Z-1060-2013·2013-04-10
Polymedco Recalls OC-Light iFOBT Test Strips Due to Stability Issues
Polymedco is recalling OC-Light iFOBT test strips because they may not be stable through their labeled shelf-life, potentially causing false negative results.
Product
Test Strips packaged in the OC-Light Manual iFOBT Kit, Catalog No. FOBSTR. For the rapid, qualitative detection of human hemoglobin in feces.
Category
Medical Device
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-214-2013·2013-03-27
Physicians Total Care Recalls Subpotent Levothyroxine Tablets
Physicians Total Care is recalling Levothyroxine Tablets, USP, 0.175 mg, due to subpotency and stability issues. The recall affects specific lots distributed in Ohio and Georgia.
Product
Levothyroxine Tablets, USP (levothyroxine sodium), 0.175 mg, 30 count bottles, Rx, Repacked & distributed by: Physicians Total Care, Inc., Tulsa, OK --- NDC 54868-4507-00
Category
Drug
Distribution
2 states
ModerateFDA (Drugs)·D-174-2013·2013-03-06
West-ward Recalls Isoniazid Tablets for Failed Dissolution Specifications
West-ward Pharmaceutical Corp. is recalling Isoniazid Tablets 300 mg due to failed dissolution specifications and a 36-month stability timepoint issue.
Product
Isoniazid Tablets 300 mg tablets USP, Rx Only, a) 30 tablets - NDC 61748-013-30, b) 100 tablets - NDC 61748-013-01, Mfd for: VersaPharm Incorporated Marietta, GA 30065-1505, Mfd by: West - Ward Pharmaceutical Corp.., Eatontown, NJ 07724
Category
Drug
Distribution
1 state
SevereFDA (Drugs)·D-101-2013·2013-01-02
Lloyd Inc. of Iowa Recalls Subpotent Levothroid Levothyroxine Sodium Tablets
Lloyd Inc. of Iowa is recalling specific lots of Levothroid (levothyroxine sodium) tablets because they are subpotent and have a 9-month stability interval.
Product
Levothroid (levothyroxine sodium tablets, USP), 50 mcg., 100-count bottles, Rx only, NDC 0456-1321-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-104-2013·2013-01-02
Alara Recalls Subpotent Levothyroxine Sodium Tablets Due to Stability Issues
Alara Pharmaceutical is recalling 7,432 bottles of Levothyroxine Sodium Tablets because the product is subpotent and has stability issues.
Product
Levothyroxine Sodium Tablets, USP, 175 mcg in 90 ct bottles, Manufactured by Patheon Puerto Rico Inc., for Alara Pharmaceutical Corp, San Juan, PR
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-100-2013·2013-01-02
Lloyd Inc. Recalls Subpotent Thyro-Tab 0.050 mg. Tablets
Lloyd Inc. of Iowa is recalling specific lots of Thyro-Tab 0.050 mg. tablets because they are subpotent and have a 9-month stability interval.
Product
Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-102-2013·2013-01-02
Lloyd Inc. Recalls Subpotent Thyro-Tab 0.075 mg. Tablets
Lloyd Inc. of Iowa is recalling 1.9 million Thyro-Tab 0.075 mg. tablets due to subpotency and stability issues.
Product
Thyro-Tab 0.075 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-103-2013·2013-01-02
Lloyd Inc. of Iowa Recalls Subpotent Levothroid 75 mcg Tablets
Lloyd Inc. of Iowa is recalling 16,548 bottles of Levothroid 75 mcg tablets because the product is subpotent and has a 9-month stability interval.
Product
Levothroid (levothyroxine sodium tablets, USP), 75 mcg., 100-count bottles, Rx only, NDC 0456-1322-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Devices)·Z-0016-2013·2012-10-17
Beckman Coulter Recalls Active Renin IRMA Kit Due to Stability Issues
Beckman Coulter is recalling the Active Renin IRMA Kit because decreased stability in coated tubes may cause falsely elevated test results.
Product
Active Renin IRMA Kit, Part Number DSL25100 Product Usage: The Renin IRMA; DSL25100 immunoradiometric assay kit provides materials for the quantitative measurement of Renin in plasma. This assay is intended for in vitro diagnostic use.
Category
Medical Device
Distribution
3 states
ModerateFDA (Drugs)·D-1695-2012·2012-10-03
Abbott Recalls Synthroid Tablets Due to Container Wall Defect
Abbott Laboratories is recalling 42,596 bottles of Synthroid (levothyroxine sodium) 75 mcg tablets due to a localized thin wall defect on the bottle bottom that may impact tablet stability.
Product
SYNTHROID — SYNTHROID (LEVOTHYROXINE SODIUM)
Category
Drug
Distribution
Distributed nationwide